Research demonstrates the progress being made in health technology assessment.
Center for Innovation & Value Research (the Center)
Latest Content
The Inflation Reduction Act proposes a significant initiative, the Drug Price Negotiation Program, aimed at tackling healthcare affordability and accessibility in the US. In this column, the importance of meaningful patient engagement during the IRA’s implementation is highlighted as a vital step towards improving health outcomes and equity for patients.
The recent collaboration between The Innovation and Value Initiative (IVI), Alliance for Aging Research, Leavitt Partners, LLC, and National Pharmaceutical Council (NPC) has shed light on critical health equity issues and patient engagement within the Drug Price Negotiation Program (DPNP) context.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Cobenfy in Practice: Hope, Hurdles, and the Next Chapter in Schizophrenia Care
2
FDA Approves Gazyva for Lupus Nephritis in Adults
3
AI in Ophthalmology: The Key to the Present Success Includes a CPT Code. The Future? Agentic AI That Doesn’t Wait To Be Told What To Do | AAO 2025
4
What’s New in the Diagnosis and Treatment of Headaches That Ophthalmologists Should Know About? | AAO 2025
5
